IMGN News Alert Immunogen (IMGN) 5.90 12/25/2014 05:37:53

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Immunogen (IMGN) 5.90 $IMGN

Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Dec 24, 8:48AM CST
Will Express Scripts' announcement regarding AbbVie's (ABBV) Viekira Pak lead to a pricing war in the hepatitis C virus (HCV) market?
BIIB: 340.89 (+5.13), VRTX: 115.15 (+1.40), CBST: 100.29 (-0.09), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), IMGN: 5.90 (+0.13), ABBV: 66.21 (+1.86)

Roche Loses A Little Luster Before Year-End
Stephen Simpson, CFA - at Seeking Alpha - Mon Dec 22, 1:45PM CST

BIIB: 340.89 (+5.13), IMGN: 5.90 (+0.13)

ImmunoGen/Roche's Kadcyla Fails in Study, Shares Plunge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 1:44PM CST
ImmunoGen (IMGN) and partner Roche's Kadcyla failed to meet the primary endpoint in a phase III study conducted in HER2-positive metastatic breast cancer patients.
LCI: 42.29 (+1.79), IMGN: 5.90 (+0.13), BIOD: 1.36 (-0.04)

Immunogen (IMGN) Showing Signs Of A Dead Cat Bounce Today
at The Street - Mon Dec 22, 8:48AM CST
Trade-Ideas LLC identified Immunogen (IMGN) as a "dead cat bounce" (down big yesterday but up big today) candidate
IMGN: 5.90 (+0.13)

ImmunoGen, Inc. Appoints Richard J. Gregory, Ph.D. as EVP, Chief Scientific Officer; John M. Lambert, Ph.D. Named EVP, Distinguished Research Fellow
Business Wire - Mon Dec 22, 5:30AM CST
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate (ADC) technology, today announced the appointment of Richard J. Gregory, Ph.D., as Executive Vice President, Research and Chief Scientific Officer (CSO), reporting to ImmunoGen President and CEO, Daniel Junius. Dr. Gregory will join the Company on January 5, 2015, at which time current CSO, John Lambert, Ph.D., will assume the position of Executive Vice President, Distinguished Research Fellow. Dr. Gregory brings to ImmunoGen deep scientific and research management experience, most recently serving as senior vice president and head of research for the Sanofi Genzyme Research & Development Center.
IMGN: 5.90 (+0.13)

Why ImmunoGen Inc. Stock Was Throttled
Sean Williams, The Motley Fool - Motley Fool - Fri Dec 19, 3:05PM CST
This article originally appeared as part of ongoing coverage in our premium  Motley Fool Rule Breakers  service... we hope you enjoy this complimentary peek! What: Shares of ImmunoGen , a biopharmaceutical company...
IMGN: 5.90 (+0.13)

Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Dec 19, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. What should the Seeking Alpha community be reading and writing about? Please leave...
SPHS: 0.46 (+0.02), ASPX: 49.93 (-0.10), MDVN: 99.23 (+1.23), CYCC: 0.69 (+0.01), OPK: 9.63 (+0.21), NLNK: 39.08 (+1.36), JUNO: 39.99 (+2.71), REGN: 400.12 (+6.07), MYGN: 36.50 (+0.28), PFE: 31.42 (-0.03), IMGN: 5.90 (+0.13), AMGN: 160.67 (+3.15), GSK: 42.85 (+0.11), BMY: 59.15 (-0.01), BLRX: 1.68 (-0.01), OREX: 5.98 (+0.01), DVA: 76.06 (+0.07), BLCM: 19.30 (+0.18), CBST: 100.29 (-0.09), GILD: 91.29 (+1.84), GERN: 3.06 (+0.05), MRK: 57.46 (+0.25), NVS: 93.91 (+0.66)

Stocks at Session Highs as Energy Sector Picks Up Steam
at The Street - Fri Dec 19, 2:04PM CST
Stocks are higher Friday, with the energy sector leading the S&P 500's gains.
KMI: 42.01 (+0.10), NKE: 96.29 (+0.32), BBRY: 10.67 (-0.13), IMGN: 5.90 (+0.13), PETX: 17.05 (+0.42), FINL: 22.79 (+0.17), SLB: 87.06 (-0.26), KMX: 67.61 (-0.15), APP: 1.06 (+0.01), RHT: 70.92 (+0.47), CVX: 113.47 (-0.48), XLE: 80.13 (-0.59), TNK: 4.74 (+0.04)

Juno Therapeutics IPO Caps Big Year In Biotech Deals
at Investor's Business Daily - Fri Dec 19, 11:47AM CST
Juno Therapeutics (JUNO) set a record as the most highly valued biotech IPO this year, with the stock jumping 62% as trading began Friday. The initial public offering raised $265 million, with the company selling 11 million shares at 24. Juno...
IMDZ: 34.96 (+0.78), BLCM: 19.30 (+0.18), KITE: 51.96 (+0.45), IMGN: 5.90 (+0.13), JUNO: 39.99 (+2.71)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 11:45AM CST

RBY: 0.91 (+0.01), FATE: 4.90 (+0.23), IMDZ: 34.96 (+0.78), RXII: 1.60 (unch), GLMD: 5.95 (+0.15), TBIO: 2.31 (-0.09), SIM: 10.11 (+0.34), PHMD: 1.46 (-0.03), IMGN: 5.90 (+0.13), PETX: 17.05 (+0.42), NQ: 4.32 (-0.36), OTIC: 32.26 (+0.65), VHC: 5.98 (-0.19), FINL: 22.79 (+0.17), BBLU: 1.15 (-0.03), TRXC: 2.79 (+0.03), BAS: 7.30 (-0.08), ENRJ: 2.43 (+0.03), TNK: 4.74 (+0.04)

Roche Drugs For Alzheimer's, Breast Cancer Disappoint
at Investor's Business Daily - Fri Dec 19, 10:31AM CST
Big Swiss pharma Roche (RHHBY) halted development of its Alzheimer's disease drug and reported mediocre results from a clinical trial of breast-cancer drug Kadcyla Friday, sending the stock down more than 6% in early trading on the stock market...
BIIB: 340.89 (+5.13), IMGN: 5.90 (+0.13), LLY: 70.16 (+0.42)

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half
at The Street - Fri Dec 19, 9:46AM CST
TheStreet's Jim Cramer takes a look at Celgene's positive news, as well as the bad news that caused shares of ImmunoGen to be nearly cut in half.
BIIB: 340.89 (+5.13), ISIS: 59.49 (+1.88), GILD: 91.29 (+1.84), IMGN: 5.90 (+0.13), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)

ImmunoGen (IMGN) Stock Plummets to One-Year Low on Disappointing Breast Cancer Drug Results
at The Street - Fri Dec 19, 9:35AM CST
Shares of ImmunoGen (IMGN) plunged more than 50% to a 52-week low of $5.36 on Friday after poor results of its experimental breast cancer treatment.
IMGN: 5.90 (+0.13)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 8:11AM CST

KMX: 67.61 (-0.15), MOLG: 2.92 (+0.03), CERS: 6.49 (+0.29), OREX: 5.98 (+0.01), APP: 1.06 (+0.01), ISIS: 59.49 (+1.88), PIR: 15.33 (-0.11), BBRY: 10.67 (-0.13), IMGN: 5.90 (+0.13), FMD: 5.06 (unch), RHT: 70.92 (+0.47), PETX: 17.05 (+0.42), NVGN: 2.40 (-0.09), TRXC: 2.79 (+0.03), NQ: 4.32 (-0.36), FINL: 22.79 (+0.17), TNK: 4.74 (+0.04)

ImmunoGen tanks on Roche Phase 3 failure
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 7:44AM CST

IMGN: 5.90 (+0.13)

ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial
Business Wire - Fri Dec 19, 12:02AM CST
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today reported that Roche has announced top-line results of its Phase III MARIANNE study.
IMGN: 5.90 (+0.13)

ImmunoGen, Inc. Announces Webcast of Presentation at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Dec 15, 11:45AM CST
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that Daniel Junius, President and CEO, will present at the upcoming 33rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for 9:00 am PT (12:00 pm ET) on January 13, 2015.
JPM: 62.48 (unch), IMGN: 5.90 (+0.13)

Lilly maxes its cancer licenses under agreement with ImmunoGen
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 9:36AM CST

IMGN: 5.90 (+0.13), LLY: 70.16 (+0.42)

ImmunoGen Reports Encouraging Data on Cancer Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 3:30PM CST
ImmunoGen (IMGN) presented encouraging data on IMGN529, being evaluated for the treatment of diffuse large B-cell lymphoma and other non-Hodgkin lymphoma subtypes.
IMGN: 5.90 (+0.13), AMGN: 160.67 (+3.15), SNY: 46.35 (+0.50)

ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition
Business Wire - Sat Dec 06, 11:01AM CST
--Dose finding is ongoing, with the maximum tolerated dose (MTD) not yet established.
IMGN: 5.90 (+0.13)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 113

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 107

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 130

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 121

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading

Top 5 Most Recently Viewed Articles

ICG Enterprise Trust plc Announces Share Repurchase Details

Updated Category News Views 159

ICG Enterprise Trust plc Share Buyback Announcement ICG Enterprise Trust plc (the “Company”) The Company has announced a recent development regarding its share buyback initiative. On a significant date, it repurchased 15,000 of its own shares aimed to be held as treasury shares, with each share valued at an average price of 1450 pence. Details of the Transaction...

Continue Reading
Converge Technology Solutions Shares Third Quarter 2024 Insights

Updated Category News Views 217

Converge Technology Solutions Announces Preliminary Q3 Results Converge Technology Solutions Corp. (CTS) has released its preliminary unaudited financial results for the third quarter of 2024. The company is committed to delivering insightful updates to its stakeholders as part of its transparency approach. The company stated that all figures are presented in Canadian...

Continue Reading
Discovery Silver Corp. Unveils 2023 ESG Report

Updated Category News Views 104

Discovery Silver Corp. Releases 2023 ESG Report Key Highlights: Earned Quality Environmental Certification from the Mexican Government Recognized as a Socially Responsible Enterprise by the Mexican Center for Philanthropy Achieved Great Place to Work Certification Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) is excited to announce the publication of its 2023...

Continue Reading
Final Call for Subscription in IDEX Biometrics Offering Today

Updated Category News Views 152

Important Subscription Period Details for IDEX Biometrics Today marks a significant turning point for IDEX Biometrics ASA as the subscription period for their subsequent offering of shares closes. The company previously announced that they aim to issue up to 600 million new shares at a remarkable subscription price of NOK 0.01 per share. This offering, essential for...

Continue Reading
Dundee Corporation Strengthens Position in Greenheart Gold Inc.

Updated Category News Views 33

Overview of Recent Acquisition Dundee Corporation (TSX: DC.A) has announced that its wholly-owned subsidiary, Dundee Resources Limited, recently acquired 2,000,000 common shares of Greenheart Gold Inc. (TSXV: GHRT) at a price of C$0.50 per share, totaling an investment of C$1,000,000. This acquisition is part of the Issuer's bought deal private placement and signifies...

Continue Reading